Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04628507 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Cell Free Preimplantation Genetic Testing

StatusNot Yet Recruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Primary completion date: Nov 11, 2024 to Nov 11, 2027
    • Start date: Jun 11, 2024 to Jun 11, 2026
    • Study completion date: Dec 11, 2024 to Dec 11, 2027
    • Site contact updated
    v6
  2. Primary completion date: Nov 11, 2023 to Nov 11, 2024
    • Start date: Jun 11, 2023 to Jun 11, 2024
    • Study completion date: Dec 11, 2023 to Dec 11, 2024
    v5
  3. Start date: Jan 11, 2023 to Jun 11, 2023
    • Site contact updated
    v4
  4. Primary completion date: Nov 11, 2022 to Nov 11, 2023v3 Show 4 more changesShow less
    • Start date: Jan 11, 2021 to Jan 11, 2023
    • Trial status: Enrolling by Invitation to Not Yet Recruiting
    • Study completion date: Jan 11, 2023 to Dec 11, 2023
    • Site contact updated
  5. Trial status: Recruiting to Enrolling by Invitation
    • Start date changed from estimate of Nov 11, 2020 to Jan 11, 2021
    • Site details revised
    v2
  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study aims to develop preimplantation genetic testing methods from embryo culture media (cell free). Genetic testing of culture media will be compared to conventional methods based on embryo biopsies.
Trial Details
NCT Number NCT04628507
Lead Sponsor Genomic Prediction Inc.
Conditions
(from sponsor)		 Infertility, Female, Infertility, Male
Related terms Infertility, Female, Infertility, Male
Enrollment 200 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov